| abstract |
The present invention is an inhibitor of dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitor”), for treating a disease involving dipeptidyl peptidase-IV enzyme, such as diabetes, particularly type 2 diabetes, or The subject is novel condensed triazole derivatives that are useful for prevention. The present invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of diseases involving the dipeptidyl peptidase-IV enzyme. |